Post-Operative Recurrent Trachomatous Trichiasis Is Associated with Increased Conjunctival Expression of S100A7 (Psoriasin)

PLoS Neglected Tropical Diseases

Volumn 6, Issue 12, 2012, Pages

  Burton, Matthew J ^a,b,c   Rajak, Saul N ^a   Ramadhani, Athumani ^b   Weiss, Helen A ^a   Habtamu, Esmael ^d   Abera, Baye ^e   Emerson, Paul M ^d   Khaw, Peng T ^c   Mabey, David C W ^a   Holland, Martin J ^a   Bailey, Robin L ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b KILIMANJARO CHRISTIAN MEDICAL CENTRE   (Tanzania)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d CARTER CENTER   (United States)

^e BAHIR DAR UNIVERSITY   (Ethiopia)

Author keywords

[No Author keywords available]

Indexed keywords

CONNECTIVE TISSUE GROWTH FACTOR; EPITHELIAL DERIVED NEUTROPHIL ACTIVATING FACTOR 78; GELATINASE B; INTERLEUKIN 1BETA; MACROPHAGE ELASTASE; MATRILYSIN; NITRIC OXIDE SYNTHASE; PSORIASIN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGE; AGED; ARTICLE; CASE CONTROL STUDY; CLINICAL ASSESSMENT; CONJUNCTIVA; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FOLLOW UP; GENDER; GENE EXPRESSION; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE PERIOD; RECURRENT DISEASE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SURGICAL TECHNIQUE; SUTURE; TRICHIASIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; FEMALE; GENE EXPRESSION; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; RECURRENCE; S100 PROTEINS; TRACHOMA; TRICHIASIS; YOUNG ADULT;

EID: 84872030577     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0001985     Document Type: Article

References (52)

1. Mariotti SP, Pascolini D, Rose-Nussbaumer J, (2009) Trachoma: global magnitude of a preventable cause of blindness. Br J Ophthalmol 93: 563-568.
2. Burton MJ, Kinteh F, Jallow O, Sillah A, Bah M, et al. (2005) A randomised controlled trial of azithromycin following surgery for trachomatous trichiasis in the Gambia. Br J Ophthalmol 89: 1282-1288.
3. West ES, Munoz B, Imeru A, Alemayehu W, Melese M, et al. (2006) The association between epilation and corneal opacity among eyes with trachomatous trichiasis. Br J Ophthalmol 90: 171-174.
4. Rajak SN, Habtamu E, Weiss HA, Bedri A, Gebre T, et al. (2012) Epilation for trachomatous trichiasis and the risk of corneal opacification. Ophthalmology 119: 84-89.
5. Burton MJ, Rajak SN, Bauer J, Weiss HA, Tolbert SB, et al. (2011) Conjunctival transcriptome in scarring trachoma. Infect Immun 79: 499-511.
6. West ES, Mkocha H, Munoz B, Mabey D, Foster A, et al. (2005) Risk factors for postsurgical trichiasis recurrence in a trachoma-endemic area. Invest Ophthalmol Vis Sci 46: 447-453.
7. Khandekar R, Mohammed AJ, Courtright P, (2001) Recurrence of trichiasis: a long-term follow-up study in the Sultanate of Oman. Ophthalmic Epidemiol 8: 155-161.
8. Rajak SN, Collin JR, Burton MJ, (2012) Trachomatous Trichiasis and its Management in Endemic Countries. Surv Ophthalmol 57: 105-135.
9. Rajak SN, Makalo P, Sillah A, Holland MJ, Mabey DC, et al. (2010) Trichiasis surgery in The Gambia: a 4-year prospective study. Invest Ophthalmol Vis Sci 51: 4996-5001.
10. Reacher MH, Munoz B, Alghassany A, Daar AS, Elbualy M, et al. (1992) A controlled trial of surgery for trachomatous trichiasis of the upper lid. Arch Ophthalmol 110: 667-674.
11. West SK, West ES, Alemayehu W, Melese M, Munoz B, et al. (2006) Single-dose azithromycin prevents trichiasis recurrence following surgery: randomized trial in Ethiopia. Arch Ophthalmol 124: 309-314.
12. Rajak SN, Habtamu E, Weiss HA, Kello AB, Gebre T, et al. (2011) Absorbable versus silk sutures for surgical treatment of trachomatous trichiasis in Ethiopia: A randomised controlled trial. PLoS Med 8: e1001137.
13. Alemayehu W, Melese M, Bejiga A, Worku A, Kebede W, et al. (2004) Surgery for trichiasis by ophthalmologists versus integrated eye care workers: a randomized trial. Ophthalmology 111: 578-584.
14. Merbs SL, Harding JC, Cassard SD, Munoz BE, West SK, et al. (2012) Relationship between immediate post-operative appearance and 6-week operative outcome in trichiasis surgery. PLoS Negl Trop Dis 6: e1718.
15. Gower EW, Merbs SL, Munoz BE, Kello AB, Alemayehu W, et al. (2011) Rates and risk factors for unfavorable outcomes 6 weeks after trichiasis surgery. Invest Ophthalmol Vis Sci 52: 2704-2711.
16. World Health O (2005) Final Assessment of Trichiasis Surgeons. Geneva: World Health Organisation.
17. Reacher MH, Huber MJ, Canagaratnam R, Alghassany A, (1990) A trial of surgery for trichiasis of the upper lid from trachoma. Br J Ophthalmol 74: 109-113.
18. Yorston D, Mabey D, Hatt S, Burton M, (2006) Interventions for trachoma trichiasis. Cochrane Database Syst Rev%19;3:CD004008: CD004008.
19. Burton MJ, Bowman RJ, Faal H, Aryee EA, Ikumapayi UN, et al. (2005) Long term outcome of trichiasis surgery in the Gambia. Br J Ophthalmol 89: 575-579.
20. Burton MJ, Bailey RL, Jeffries D, Rajak SN, Adegbola RA, et al. (2010) Conjunctival expression of matrix metalloproteinase and proinflammatory cytokine genes after trichiasis surgery. Invest Ophthalmol Vis Sci 51: 3583-3590.
21. Burton MJ, Ramadhani A, Weiss HA, Hu VH, Massae P, et al. (2011) Active trachoma is associated with increased conjunctival expression of IL17A and pro-fibrotic cytokines. Infect Immun 79: 4977-4983.
22. Zhang H, Kandel RP, Atakari HK, Dean D, (2006) Impact of oral azithromycin on recurrence of trachomatous trichiasis in Nepal over 1 year. Br J Ophthalmol 90: 943-948.
23. Dawson CR, Jones BR, Tarizzo ML (1981) Guide to Trachoma Control. Geneva: World Health Organization.
24. Livak KJ, Schmittgen TD, (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408.
25. Rajak SN, Habtamu E, Weiss HA, Kello AB, Gebre T, et al. (2011) Surgery versus epilation for the treatment of minor trichiasis in Ethiopia: a randomised controlled noninferiority trial. PLoS Med 8: e1001136.
26. Hu VH, Weiss HA, Ramadhani AM, Tolbert SB, Massae P, et al. (2012) Innate immune responses and modified extracellular matrix regulation characterize bacterial infection and cellular/connective tissue changes in scarring trachoma. Infect Immun 80: 121-130.
27. Eckert RL, Broome AM, Ruse M, Robinson N, Ryan D, et al. (2004) S100 proteins in the epidermis. J Invest Dermatol 123: 23-33.
28. Madsen P, Rasmussen HH, Leffers H, Honore B, Dejgaard K, et al. (1991) Molecular cloning, occurrence, and expression of a novel partially secreted protein "psoriasin" that is highly up-regulated in psoriatic skin. J Invest Dermatol 97: 701-712.
29. Leygue E, Snell L, Hiller T, Dotzlaw H, Hole K, et al. (1996) Differential expression of psoriasin messenger RNA between in situ and invasive human breast carcinoma. Cancer Res 56: 4606-4609.
30. Al-Haddad S, Zhang Z, Leygue E, Snell L, Huang A, et al. (1999) Psoriasin (S100A7) expression and invasive breast cancer. Am J Pathol 155: 2057-2066.
31. Zhang H, Zhao Q, Chen Y, Wang Y, Gao S, et al. (2008) Selective expression of S100A7 in lung squamous cell carcinomas and large cell carcinomas but not in adenocarcinomas and small cell carcinomas. Thorax 63: 352-359.
32. Tripathi SC, Matta A, Kaur J, Grigull J, Chauhan SS, et al. (2010) Nuclear S100A7 is associated with poor prognosis in head and neck cancer. PLoS One 5: e11939.
33. West NR, Watson PH, (2010) S100A7 (psoriasin) is induced by the proinflammatory cytokines oncostatin-M and interleukin-6 in human breast cancer. Oncogene 29: 2083-2092.
34. Ye L, Sun PH, Martin TA, Sanders AJ, Mason MD, et al. (2012) Psoriasin (S100A7) is a positive regulator of survival and invasion of prostate cancer cells. Urol Oncol.
35. Nasser MW, Qamri Z, Deol YS, Ravi J, Powell CA, et al. (2012) S100A7 enhances mammary tumorigenesis through upregulation of inflammatory pathways. Cancer Res 72: 604-615.
36. Qin W, Ho L, Wang J, Peskind E, Pasinetti GM, (2009) S100A7, a novel Alzheimer's disease biomarker with non-amyloidogenic alpha-secretase activity acts via selective promotion of ADAM-10. PLoSONE 4: e4183.
37. Glaser R, Harder J, Lange H, Bartels J, Christophers E, et al. (2005) Antimicrobial psoriasin (S100A7) protects human skin from Escherichia coli infection. NatImmunol 6: 57-64.
38. Michalek M, Gelhaus C, Hecht O, Podschun R, Schroder JM, et al. (2009) The human antimicrobial protein psoriasin acts by permeabilization of bacterial membranes. DevComp Immunol 33: 740-746.
39. Andresen E, Lange C, Strodthoff D, Goldmann T, Fischer N, et al. (2011) S100A7/psoriasin expression in the human lung: unchanged in patients with COPD, but upregulated upon positive S. aureus detection. BMC Pulm Med 11: 10.
40. Meyer-Hoffert U, Zimmermann A, Czapp M, Bartels J, Koblyakova Y, et al. (2011) Flagellin delivery by Pseudomonas aeruginosa rhamnolipids induces the antimicrobial protein psoriasin in human skin. PLoS One 6: e16433.
41. Jinquan T, Vorum H, Larsen CG, Madsen P, Rasmussen HH, et al. (1996) Psoriasin: a novel chemotactic protein. J Invest Dermatol 107: 5-10.
42. Wolf R, Howard OM, Dong HF, Voscopoulos C, Boeshans K, et al. (2008) Chemotactic activity of S100A7 (Psoriasin) is mediated by the receptor for advanced glycation end products and potentiates inflammation with highly homologous but functionally distinct S100A15. J Immunol 181: 1499-1506.
43. Wolf R, Mascia F, Dharamsi A, Howard OM, Cataisson C, et al. (2010) Gene from a psoriasis susceptibility locus primes the skin for inflammation. Sci Transl Med 2: 61ra90.
44. Zheng Y, Niyonsaba F, Ushio H, Ikeda S, Nagaoka I, et al. (2008) Microbicidal protein psoriasin is a multifunctional modulator of neutrophil activation. Immunology 124: 357-367.
45. Abtin A, Eckhart L, Mildner M, Gruber F, Schroder JM, et al. (2008) Flagellin is the principal inducer of the antimicrobial peptide S100A7c (psoriasin) in human epidermal keratinocytes exposed to Escherichia coli. FASEB J 22: 2168-2176.
46. Guilloteau K, Paris I, Pedretti N, Boniface K, Juchaux F, et al. (2010) Skin Inflammation Induced by the Synergistic Action of IL-17A, IL-22, Oncostatin M, IL-1{alpha}, and TNF-{alpha} Recapitulates Some Features of Psoriasis. J Immunol.
47. Petersson S, Bylander A, Yhr M, Enerback C, (2007) S100A7 (Psoriasin), highly expressed in ductal carcinoma in situ (DCIS), is regulated by IFN-gamma in mammary epithelial cells. BMC Cancer 7:205: 205.
48. Holland MJ, Bailey RL, Conway DJ, Culley F, Miranpuri G, et al. (1996) T helper type-1 (Th1)/Th2 profiles of peripheral blood mononuclear cells (PBMC); responses to antigens of Chlamydia trachomatis in subjects with severe trachomatous scarring. Clin Exp Immunol 105: 429-435.
49. Rajak SN, Habtamu E, Weiss HA, Bedri A, Gebre T, et al. (2011) The clinical phenotype of trachomatous trichiasis in Ethiopia: not all trichiasis is due to entropion. Invest Ophthalmol Vis Sci 52: 7974-7980.
50. Dawson CR, Marx R, Daghfous T, Juster R, Schachter J (1990) What clinical signs are critical in evaluating the intervention in trachoma? In: Bowie WR, editor. Chlamydial Infections. Cambridge: Cambridge University Press. pp. 271-278.
51. West SK, Munoz B, Mkocha H, Hsieh YH, Lynch MC, (2001) Progression of active trachoma to scarring in a cohort of Tanzanian children. Ophthalmic Epidemiol 8: 137-144.
52. Dahlmann AH, Mireskandari K, Cambrey AD, Bailly M, Khaw PT, (2005) Current and future prospects for the prevention of ocular fibrosis. Ophthalmol Clin North Am 18: 539-559.